Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shirai

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Carcinogenesis|October 7, 2000
p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesisM Yamamoto, T Tsukamoto, H Sakai, et al.
Neuroscience|April 19, 2011
In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's diseaseD Yanagisawa, T Amatsubo, S Morikawa, et al.
Cancer Research|June 1, 1986
Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridineA W Wood, R L Chang, W Levin, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 24, 1999
[A case of non-functioning malignant islet cell tumor with egg-shaped calcification]K Hirano, H Kataoka, M Nagasawa, et al.
Alimentary Pharmacology & Therapeutics|August 14, 2012
Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotypeM Sugimoto, N Shirai, M Nishino, et al.
Clinical Pharmacology and Therapeutics|October 8, 1999
Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humansT Furuta, K Ohashi, K Kobayashi, et al.
Leukemia|May 28, 2005
Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cellsA Takeshita, K Shinjo, K Naito, et al.
Clinical Pharmacology and Therapeutics|January 12, 2007
Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pyloriT Furuta, N Shirai, M Kodaira, et al.
Cancer Research|September 1, 1986
High tumorigenicity of the 3,4-dihydrodiol of 7-methylbenz[c]acridine on mouse skin and in newborn miceR L Chang, W Levin, A W Wood, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pHN Shirai, T Furuta, Y Moriyama, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Carcinogenesis|October 7, 2000
p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesisM Yamamoto, T Tsukamoto, H Sakai, et al.
Neuroscience|April 19, 2011
In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's diseaseD Yanagisawa, T Amatsubo, S Morikawa, et al.
Cancer Research|June 1, 1986
Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridineA W Wood, R L Chang, W Levin, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 24, 1999
[A case of non-functioning malignant islet cell tumor with egg-shaped calcification]K Hirano, H Kataoka, M Nagasawa, et al.
Alimentary Pharmacology & Therapeutics|August 14, 2012
Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotypeM Sugimoto, N Shirai, M Nishino, et al.
Clinical Pharmacology and Therapeutics|October 8, 1999
Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humansT Furuta, K Ohashi, K Kobayashi, et al.
Leukemia|May 28, 2005
Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cellsA Takeshita, K Shinjo, K Naito, et al.
Clinical Pharmacology and Therapeutics|January 12, 2007
Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pyloriT Furuta, N Shirai, M Kodaira, et al.
Cancer Research|September 1, 1986
High tumorigenicity of the 3,4-dihydrodiol of 7-methylbenz[c]acridine on mouse skin and in newborn miceR L Chang, W Levin, A W Wood, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pHN Shirai, T Furuta, Y Moriyama, et al.
Pageof 8